RPM Again Flouted In The UK By AZDA

16 June 1996

Whitehall Labs has won a temporary injunction against UK superstore ASDA, which last week started selling its analgesic Anadin paracetamol at half the normal price, in contravention of Retail Price Maintenance conditions.

The Community Pharmacy Action Group also condemned ASDA's move, saying not only does this contravene RPM, it is irresponsible and against the public interest. The Office of Fair Trading launched a review into RPM on medicines in October 1995 (when ASDA started selling cut-price vitamins); it is due to report its findings later this year. The CPAG also argues that the removal of RPM on non-prescription medicines would put many small pharmacies at risk of closure, claiming the issue is safeguarding long-term professional health care in the community.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight